Oral triptan prescription patterns in the United States: A review of three administrative claims databases

Christopher F. Bell, Kathleen A. Foley, Suna Barlas, Brian Mondell, X. Henry Hu

Research output: Contribution to journalReview article

Abstract

From January 1, 2001 through December 31, 2002, the number of rizatriptan, sumatriptan, and zolmitriptan tablets dispensed was assessed using three administrative claims databases. Oral triptan costs were estimated using 2002 wholesale acquisition costs. The annualized number of tablets dispensed was, on average, significantly less for rizatriptan versus sumatriptan (9.6-10.7; P < .001) and zolmitriptan (2.4-5.5; P < .001). Per-patient oral triptan costs were lower for rizatriptan versus sumatriptan ($244-$305 less) and zolmitriptan ($62-$126 less). Rizatriptan was associated with lower tablet utilization compared with patients who were prescribed sumatriptan and zolmitriptan.

Original languageEnglish (US)
JournalManaged Care Interface
Volume18
Issue number11
StatePublished - Nov 2005

Fingerprint

zolmitriptan
Tryptamines
Sumatriptan
Prescriptions
Databases
Tablets
Costs and Cost Analysis
rizatriptan

ASJC Scopus subject areas

  • Health Policy

Cite this

Oral triptan prescription patterns in the United States : A review of three administrative claims databases. / Bell, Christopher F.; Foley, Kathleen A.; Barlas, Suna; Mondell, Brian; Hu, X. Henry.

In: Managed Care Interface, Vol. 18, No. 11, 11.2005.

Research output: Contribution to journalReview article

Bell, Christopher F. ; Foley, Kathleen A. ; Barlas, Suna ; Mondell, Brian ; Hu, X. Henry. / Oral triptan prescription patterns in the United States : A review of three administrative claims databases. In: Managed Care Interface. 2005 ; Vol. 18, No. 11.
@article{d77948e026b34f3e95182fd20e20f0c9,
title = "Oral triptan prescription patterns in the United States: A review of three administrative claims databases",
abstract = "From January 1, 2001 through December 31, 2002, the number of rizatriptan, sumatriptan, and zolmitriptan tablets dispensed was assessed using three administrative claims databases. Oral triptan costs were estimated using 2002 wholesale acquisition costs. The annualized number of tablets dispensed was, on average, significantly less for rizatriptan versus sumatriptan (9.6-10.7; P < .001) and zolmitriptan (2.4-5.5; P < .001). Per-patient oral triptan costs were lower for rizatriptan versus sumatriptan ($244-$305 less) and zolmitriptan ($62-$126 less). Rizatriptan was associated with lower tablet utilization compared with patients who were prescribed sumatriptan and zolmitriptan.",
author = "Bell, {Christopher F.} and Foley, {Kathleen A.} and Suna Barlas and Brian Mondell and Hu, {X. Henry}",
year = "2005",
month = "11",
language = "English (US)",
volume = "18",
journal = "Managed Care Interface",
issn = "1096-5645",
publisher = "Medicom International, Inc.",
number = "11",

}

TY - JOUR

T1 - Oral triptan prescription patterns in the United States

T2 - A review of three administrative claims databases

AU - Bell, Christopher F.

AU - Foley, Kathleen A.

AU - Barlas, Suna

AU - Mondell, Brian

AU - Hu, X. Henry

PY - 2005/11

Y1 - 2005/11

N2 - From January 1, 2001 through December 31, 2002, the number of rizatriptan, sumatriptan, and zolmitriptan tablets dispensed was assessed using three administrative claims databases. Oral triptan costs were estimated using 2002 wholesale acquisition costs. The annualized number of tablets dispensed was, on average, significantly less for rizatriptan versus sumatriptan (9.6-10.7; P < .001) and zolmitriptan (2.4-5.5; P < .001). Per-patient oral triptan costs were lower for rizatriptan versus sumatriptan ($244-$305 less) and zolmitriptan ($62-$126 less). Rizatriptan was associated with lower tablet utilization compared with patients who were prescribed sumatriptan and zolmitriptan.

AB - From January 1, 2001 through December 31, 2002, the number of rizatriptan, sumatriptan, and zolmitriptan tablets dispensed was assessed using three administrative claims databases. Oral triptan costs were estimated using 2002 wholesale acquisition costs. The annualized number of tablets dispensed was, on average, significantly less for rizatriptan versus sumatriptan (9.6-10.7; P < .001) and zolmitriptan (2.4-5.5; P < .001). Per-patient oral triptan costs were lower for rizatriptan versus sumatriptan ($244-$305 less) and zolmitriptan ($62-$126 less). Rizatriptan was associated with lower tablet utilization compared with patients who were prescribed sumatriptan and zolmitriptan.

UR - http://www.scopus.com/inward/record.url?scp=28144459618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28144459618&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:28144459618

VL - 18

JO - Managed Care Interface

JF - Managed Care Interface

SN - 1096-5645

IS - 11

ER -